Your browser doesn't support javascript.
loading
A phase II trial of first-line sorafenib in patients with metastatic renal cell carcinoma unwilling to receive or with early intolerance to immunotherapy: SOGUG Study 06-01
Bellmunt, J; Maroto-Rey, P; Trigo, J. M; Carles, J; Guillem, V; López-Martín, J. A; Antón-Torres, A; Urruticoechea, L.
Affiliation
  • Bellmunt, J; University Hospital del Mar. Barcelona. Spain
  • Maroto-Rey, P; Sant Pau Hospital. Barcelona. Spain
  • Trigo, J. M; Vall d´Hebrón University Hospital. Barcelona. Spain
  • Carles, J; University Hospital del Mar. Barcelona. Spain
  • Guillem, V; University of Valencia. Valencia. Spain
  • López-Martín, J. A; University Hospital 12 de Octubre. Madrid. Spain
  • Antón-Torres, A; University Hospital Miguel Servet. Zaragoza. Spain
  • Urruticoechea, L; Bayer Schering Pharma. Barcelona. Spain
Clin. transl. oncol. (Print) ; 12(7): 503-508, jul. 2010. tab, ilus
Article in English | IBECS | ID: ibc-124105
Responsible library: ES1.1
Localization: BNCS
ABSTRACT

AIMS:

Our aim was to evaluate first-line treatment of metastatic renal cell carcinoma (mRCC) with sorafenib in patients unwilling to receive immunotherapy or with early in
Subject(s)
Search on Google
Add to My VHL
Print
XML
Collection: National databases / Spain Database: IBECS Main subject: Pyridines / Benzenesulfonates / Carcinoma, Renal Cell / Kidney Neoplasms / Antineoplastic Agents Limits: Aged / Female / Humans / Male Language: English Journal: Clin. transl. oncol. (Print) Year: 2010 Document type: Article Institution/Affiliation country: Bayer Schering Pharma/Spain / Sant Pau Hospital/Spain / University Hospital 12 de Octubre/Spain / University Hospital Miguel Servet/Spain / University Hospital del Mar/Spain / University of Valencia/Spain / Vall d´Hebrón University Hospital/Spain
Search on Google
Add to My VHL
Print
XML
Collection: National databases / Spain Database: IBECS Main subject: Pyridines / Benzenesulfonates / Carcinoma, Renal Cell / Kidney Neoplasms / Antineoplastic Agents Limits: Aged / Female / Humans / Male Language: English Journal: Clin. transl. oncol. (Print) Year: 2010 Document type: Article Institution/Affiliation country: Bayer Schering Pharma/Spain / Sant Pau Hospital/Spain / University Hospital 12 de Octubre/Spain / University Hospital Miguel Servet/Spain / University Hospital del Mar/Spain / University of Valencia/Spain / Vall d´Hebrón University Hospital/Spain